BioNexus Gene Lab Corp.(BGLC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BGLC BioNexus Gene Lab Corp.

交易中 05-04 15:44:30 EDT

2.05

+0.03

+1.49%

最高2.09	最低2.05	成交量1,799
今开2.09	昨收2.02	日振幅2.01%
总市值495.55万	流通市值359.47万	总股本241.73万
成交额3,723	换手率0.10%	流通股本175.35万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BGLC","market":"US","secType":"STK","nameCN":"BioNexus Gene Lab Corp.","latestPrice":2.05,"timestamp":1777923620614,"preClose":2.02,"halted":0,"volume":1799,"delay":0,"changeRate":0.014851485148514755,"floatShares":1753500,"shares":2417314,"eps":-1.607496,"marketStatus":"交易中","change":0.03,"latestTime":"05-04 15:44:30 EDT","open":2.0905,"high":2.0905,"low":2.05,"amount":3722.5890253999996,"amplitude":0.02005,"askPrice":2.1,"askSize":312,"bidPrice":2.03,"bidSize":125,"shortable":3,"etf":0,"ttmEps":-1.607496,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1777924800000},"marketStatusCode":2,"adr":0,"listingDate":1689825600000,"exchange":"NASDAQ","adjPreClose":2.02,"preHourTrading":{"tag":"盘前","latestPrice":2.07,"preClose":2.02,"latestTime":"04:00 EDT","volume":34,"amount":70.38,"timestamp":1777881626448,"change":0.05,"changeRate":0.024752,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.0733,"preClose":2.0787,"latestTime":"19:51 EDT","volume":112,"amount":232.2219,"timestamp":1777679489995,"change":-0.0054,"changeRate":-0.002598,"amplitude":0.002598},"volumeRatio":0.299009},"requestUrl":"/m/hq/s/BGLC","defaultTab":"news","newsList":[{"id":"2619104160","title":"Bionexus Gene Lab Corp盘中异动 临近收盘快速拉升5.94%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619104160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619104160?lang=zh_cn&edition=full","pubTime":"2026-03-13 03:56","pubTimestamp":1773345361,"startTime":"0","endTime":"0","summary":"北京时间2026年03月13日03时56分，Bionexus Gene Lab Corp股票出现波动，股价急速上涨5.94%。截至发稿，该股报2.32美元/股，成交量4115股，换手率0.17%，振幅1.58%。Bionexus Gene Lab Corp股票所在的化学制品行业中，整体涨幅为0.77%。Bionexus Gene Lab Corp公司简介：BioNexus Gene Lab Corp 通过其全资子公司，专注于向东南亚地区的工业、医疗、家电、航空、汽车、机械和电子行业销售化学原材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031303560297aff194&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031303560297aff194&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4104","BGLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156997947","title":"BioNexus Gene Lab Corp. 任命Muthu Meyyappan博士为Fidelion Diagnostics首席商务官，主导Vitaguard™ MRD平台全球商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1156997947","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156997947?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:46","pubTimestamp":1773233210,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab Corp. (BGLC) 宣布一项关键人事任命，Muthu Meyyappan博士已正式加入其子公司Fidelion Diagnostics，担任首席商务官。在这一新职位上，Meyyappan博士将承担起领导Vitaguard™ MRD（微小残留病灶）检测平台全球商业化战略的重任。此次任命旨在加速该前沿诊断技术的市场推广与应用，扩大其全球影响力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153874259","title":"BioNexus Gene Lab Corp. 完成Chemrex治理架构重组，任命Matthew Barsing为董事会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=1153874259","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153874259?lang=zh_cn&edition=full","pubTime":"2026-02-23 21:31","pubTimestamp":1771853474,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab Corp. (简称BGLC) 已正式完成对Chemrex的治理架构重组工作。此次重组标志着公司在优化管理体系方面迈出关键一步。与此同时，BioNexus Gene Lab Corp. 宣布任命Matthew Barsing担任董事会主席一职，这一人事变动有望为公司的战略发展注入新的领导力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611198861","title":"Bionexus Gene Lab Corp盘中异动 早盘大幅拉升7.88%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611198861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611198861?lang=zh_cn&edition=full","pubTime":"2026-02-14 00:03","pubTimestamp":1770998613,"startTime":"0","endTime":"0","summary":"北京时间2026年02月14日00时03分，Bionexus Gene Lab Corp股票出现异动，股价急速上涨7.88%。Bionexus Gene Lab Corp股票所在的化学制品行业中，整体涨幅为0.36%。Bionexus Gene Lab Corp公司简介：BioNexus Gene Lab Corp 通过其全资子公司，专注于向东南亚地区的工业、医疗、家电、航空、汽车、机械和电子行业销售化学原材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021400033495411626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021400033495411626&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609343862","title":"Bionexus Gene Lab Corp盘中异动 早盘快速下挫7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609343862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609343862?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:31","pubTimestamp":1770215473,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日22时31分，Bionexus Gene Lab Corp股票出现波动，股价大幅跳水7.17%。Bionexus Gene Lab Corp股票所在的化学制品行业中，整体涨幅为0.46%。其相关个股中，艾仕得涂料系统、卡博特、利安德巴塞尔涨幅较大，Bionexus Gene Lab Corp、中北能、Aemetis, Inc较为活跃，换手率分别为0.94%、0.43%、0.16%，振幅较大的相关个股有Aemetis, Inc、卡博特、Trinseo Plc，振幅分别为5.29%、5.24%、2.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204223113a47c5031&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204223113a47c5031&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4104","BGLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159725835","title":"BioNexus Gene Lab完成对Fidelion Diagnostics的战略投资，获得全球AI肿瘤平台15%的股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1159725835","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159725835?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:10","pubTimestamp":1764771031,"startTime":"0","endTime":"0","summary":"12月3日 - BioNexus Gene Lab Corp. ：*BioNexus Gene Lab Corp. 完成对Fidelion Diagnostics的战略投资；获得全球AI肿瘤平台15%的股权以及Vitagard™在东南亚的独占权益*。BioNexus Gene Lab Corp. 购买了Fidelion Diagnostics 15%的股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123933478","title":"BioNexus Gene Lab Corp. 完成对 Fidelion Diagnostics 的战略投资；获得全球AI肿瘤平台15%股权及Vitaguard™在东南亚的独家权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1123933478","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123933478?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:46","pubTimestamp":1764769569,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab Corp. 完成对 Fidelion Diagnostics 的战略投资；获得全球AI肿瘤平台15%股权及Vitaguard™在东南亚的独家权利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588066397","title":"Bionexus Gene Lab Corp盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588066397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588066397?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:45","pubTimestamp":1764686721,"startTime":"0","endTime":"0","summary":"北京时间2025年12月02日22时45分，Bionexus Gene Lab Corp股票出现波动，股价快速下挫5.02%。Bionexus Gene Lab Corp股票所在的化学制品行业中，整体跌幅为0.22%。Bionexus Gene Lab Corp公司简介：BioNexus Gene Lab Corp 通过其全资子公司，专注于向东南亚地区的工业、医疗、家电、航空、汽车、机械和电子行业销售化学原材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512022245219526edf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512022245219526edf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174668509","title":"BioNexus Gene Lab Corp申请最高达1亿美元的混合货架注册 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1174668509","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174668509?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:12","pubTimestamp":1763572352,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab Corp ::*BioNexus Gene Lab Corp申请最高达1亿美元的混合货架注册 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195778752","title":"BioNexus Gene Lab Corp - 将获得15%的Fidelion股份；Fidelion将获得Bglc 19.9%的前期流通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1195778752","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195778752?lang=zh_cn&edition=full","pubTime":"2025-11-12 21:03","pubTimestamp":1762952593,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab Corp - 将获得15%的Fidelion股份；Fidelion将获得Bglc 19.9%的前期流通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BGLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109810918","title":"BioNexus Gene Lab Corp.：交易完成需依赖知识产权许可协议，授予BGLC在东南亚的独家商业化权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1109810918","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109810918?lang=zh_cn&edition=full","pubTime":"2025-11-12 21:03","pubTimestamp":1762952593,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab Corp.：交易完成需依赖知识产权许可协议，授予BGLC在东南亚的独家商业化权利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184697608","title":"BioNexus Gene Lab Corp. 与 Fidelion Diagnostics 签署战略协议，推动东南亚 MRD 商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1184697608","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184697608?lang=zh_cn&edition=full","pubTime":"2025-11-12 21:01","pubTimestamp":1762952474,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab Corp. 与 Fidelion Diagnostics 签署战略协议，推动东南亚 MRD 商业化","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BGLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152386998","title":"BioNexus Gene Lab Corp. 提交1亿美元的备注册，并建立2000万美元的市场实时出售计划以推动战略增长机会","url":"https://stock-news.laohu8.com/highlight/detail?id=1152386998","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152386998?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:03","pubTimestamp":1762779794,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab Corp. 提交了1亿美元的备注册，并建立了一个2000万美元的市场实时出售计划，以推动其战略增长机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134533603","title":"BioNexus Gene Lab Corp: BGLC将通过战略股权投资主导Birch即将进行的1000万美元融资轮","url":"https://stock-news.laohu8.com/highlight/detail?id=1134533603","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134533603?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:01","pubTimestamp":1760961696,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab Corp: BGLC将通过战略股权投资主导Birch即将进行的1000万美元融资轮。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518247902","title":"Bionexus Gene Lab Corp盘中异动 早盘快速拉升6.75%报0.394美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518247902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518247902?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613462,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Bionexus Gene Lab Corp股票出现波动，股价快速上涨6.75%。Bionexus Gene Lab Corp股票所在的化学制品行业中，整体跌幅为0.34%。Bionexus Gene Lab Corp公司简介：BioNexus Gene Lab Corp 通过其全资子公司，专注于销售用于东南亚地区工业、医疗、家电、航空、汽车、机械和电子行业制造的化学原材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213102a26a242d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213102a26a242d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517569165","title":"Bionexus Gene Lab Corp盘中异动 大幅拉升9.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517569165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517569165?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:30","pubTimestamp":1741271425,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时30分，Bionexus Gene Lab Corp股票出现异动，股价大幅上涨9.78%。Bionexus Gene Lab Corp股票所在的化学制品行业中，整体涨幅为0.00%。Bionexus Gene Lab Corp公司简介：BioNexus Gene Lab Corp 通过其全资子公司，专注于销售用于东南亚地区工业、医疗、家电、航空、汽车、机械和电子行业制造的化学原材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223026abeb76f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223026abeb76f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517303949","title":"Bionexus Gene Lab Corp盘中异动 股价大涨9.99%报0.360美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517303949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517303949?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:00","pubTimestamp":1741190456,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时00分，Bionexus Gene Lab Corp股票出现波动，股价急速拉升9.99%。Bionexus Gene Lab Corp股票所在的化学制品行业中，整体涨幅为0.75%。Bionexus Gene Lab Corp公司简介：BioNexus Gene Lab Corp 通过其全资子公司，专注于销售用于东南亚地区工业、医疗、家电、航空、汽车、机械和电子行业制造的化学原材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306000057989d5b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306000057989d5b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4104","BGLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516672720","title":"Bionexus Gene Lab Corp盘中异动 早盘股价大跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516672720?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:39","pubTimestamp":1741099151,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时39分，Bionexus Gene Lab Corp股票出现波动，股价急速下挫5.40%。Bionexus Gene Lab Corp股票所在的化学制品行业中，整体涨幅为0.02%。Bionexus Gene Lab Corp公司简介：BioNexus Gene Lab Corp 通过其全资子公司，专注于销售用于东南亚地区工业、医疗、家电、航空、汽车、机械和电子行业制造的化学原材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223911989bae63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223911989bae63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514332576","title":"Bionexus Gene Lab Corp盘中异动 大幅下跌5.07%报0.333美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514332576?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:46","pubTimestamp":1740685565,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时46分，Bionexus Gene Lab Corp股票出现波动，股价急速下挫5.07%。截至发稿，该股报0.333美元/股，成交量2.2053万股，换手率0.12%，振幅6.27%。Bionexus Gene Lab Corp股票所在的化学制品行业中，整体跌幅为0.11%。Bionexus Gene Lab Corp公司简介：BioNexus Gene Lab Corp 通过其全资子公司，专注于销售用于东南亚地区工业、医疗、家电、航空、汽车、机械和电子行业制造的化学原材料。其非侵入性血液检测可分析 RNA 的变化，以检测 11 种不同疾病的潜在风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228034605abdfb3ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228034605abdfb3ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4104","BGLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513029025","title":"Bionexus Gene Lab Corp盘中异动 临近午盘股价大涨5.26%报0.360美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513029025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513029025?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:55","pubTimestamp":1740156946,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日00时55分，Bionexus Gene Lab Corp股票出现异动，股价快速拉升5.26%。截至发稿，该股报0.360美元/股，成交量1.4933万股，换手率0.08%，振幅5.56%。Bionexus Gene Lab Corp股票所在的化学制品行业中，整体涨幅为0.19%。Bionexus Gene Lab Corp公司简介：BioNexus Gene Lab Corp 通过其全资子公司，专注于销售用于东南亚地区工业、医疗、家电、航空、汽车、机械和电子行业制造的化学原材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222005546abd7ce7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222005546abd7ce7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bionexusgenelab.com","stockEarnings":[{"period":"1week","weight":-0.0636},{"period":"1month","weight":-0.0843},{"period":"3month","weight":-0.1995},{"period":"6month","weight":-0.6165},{"period":"1year","weight":-0.2543},{"period":"ytd","weight":-0.4737}],"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0998},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.0566},{"period":"1year","weight":0.2904},{"period":"ytd","weight":0.0568}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioNexus Gene Lab Corp.于2017年5月12日在怀俄明州成立。该公司通过其在马来西亚的两个主要子公司运营：Chemrex Corporation Sdn. Bhd.，分销用于工业应用的化学原材料；以及MRNA Scientific Sdn. Bhd.，提供基于血液的基因组筛查服务。此外，公司还就一项东南亚地区微小残留病平台达成了许可协议。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.030384},{"month":2,"riseRate":0.5,"avgChangeRate":-0.057854},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.049778},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.070035},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.102531},{"month":6,"riseRate":0.2,"avgChangeRate":-0.096252},{"month":7,"riseRate":0.6,"avgChangeRate":0.191553},{"month":8,"riseRate":0.4,"avgChangeRate":0.000036},{"month":9,"riseRate":0.2,"avgChangeRate":-0.161516},{"month":10,"riseRate":0.333333,"avgChangeRate":0.085347},{"month":11,"riseRate":0.5,"avgChangeRate":0.129387},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.061457}],"exchange":"NASDAQ","name":"BioNexus Gene Lab Corp.","nameEN":"BioNexus Gene Lab Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioNexus Gene Lab Corp.(BGLC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioNexus Gene Lab Corp.(BGLC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioNexus Gene Lab Corp.,BGLC,BioNexus Gene Lab Corp.股票,BioNexus Gene Lab Corp.股票老虎,BioNexus Gene Lab Corp.股票老虎国际,BioNexus Gene Lab Corp.行情,BioNexus Gene Lab Corp.股票行情,BioNexus Gene Lab Corp.股价,BioNexus Gene Lab Corp.股市,BioNexus Gene Lab Corp.股票价格,BioNexus Gene Lab Corp.股票交易,BioNexus Gene Lab Corp.股票购买,BioNexus Gene Lab Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioNexus Gene Lab Corp.(BGLC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioNexus Gene Lab Corp.(BGLC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}